Toshikazu Moriwaki
AuthID: R-00J-64Q
1
TITLE: Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-)181 study.
AUTHORS: Takashi Kojima; Kei Muro; Eric Francois; Chih Hung Hsu; Toshikazu Moriwaki; Sung Bae Kim; Se Hoon Lee; Jaafar Bennouna; Ken Kato; Shen Lin; Shi Qui Qin; Paula Ferreira; Toshihiko Doi; Antoine Adenis; Peter C Enzinger; Manish A Shah; Ruixue X Wang; Pooja Bhagia; Peter P Kang; Jean Philippe Metges;
PUBLISHED: 2019, SOURCE: Gastrointestinal Cancers Symposium in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 4
AUTHORS: Takashi Kojima; Kei Muro; Eric Francois; Chih Hung Hsu; Toshikazu Moriwaki; Sung Bae Kim; Se Hoon Lee; Jaafar Bennouna; Ken Kato; Shen Lin; Shi Qui Qin; Paula Ferreira; Toshihiko Doi; Antoine Adenis; Peter C Enzinger; Manish A Shah; Ruixue X Wang; Pooja Bhagia; Peter P Kang; Jean Philippe Metges;
PUBLISHED: 2019, SOURCE: Gastrointestinal Cancers Symposium in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 4
INDEXED IN: 
WOS
WOS